Clinical Research Directory
Browse clinical research sites, groups, and studies.
Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation
Sponsor: Stanford University
Summary
Ketamine is an anesthetic drug that is sometimes used to relieve chronic pain. The goal of this observational study is to learn about how patients respond to ketamine infusions for chronic pain. Note: This study does not provide ketamine - instead, this study uses surveys to follow patients who are already scheduled to receive ketamine infusions as part of their regular medical care. We will also follow a second group of patients who were recommended ketamine infusions by their doctor but were denied insurance coverage for this treatment. These participants will complete the same surveys for up to 16 weeks, starting from when their treatment was originally scheduled. Comparing this group to patients who received ketamine will help researchers better understand ketamine's effects and how insurance denials affect chronic pain patients.
Official title: Nationwide Observational Registry of Patient Outcomes Following Ketamine Infusion Therapy for Chronic Pain
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
800
Start Date
2026-10
Completion Date
2034-12
Last Updated
2026-09-15
Healthy Volunteers
No
Conditions
Interventions
Ketamine (Ketalar)
Intravenous ketamine infusion delivered as part of routine clinical care
Locations (1)
Stanford Health Care
Stanford, California, United States